helvy.co.uk

Hormones

IGF-1 (Insulin-like Growth Factor 1)

Insulin-like Growth Factor 1 is a peptide hormone produced primarily by the liver in response to growth hormone (GH) stimulation. Unlike GH, which is released in pulsatile bursts, IGF-1 circulates at relatively stable levels throughout the day — making it a far more reliable marker of GH axis activity. IGF-1 mediates most of the anabolic effects attributed to growth hormone: muscle protein synthesis, bone density maintenance, tissue repair, and cellular regeneration.


Optimal Ranges

Clinical (NHS) Range

10–36 nmol/L (age-dependent — declines ~14% per decade after 30)

nmol/L

Performance-Optimised Range

18–28 nmol/L (mid-range, balancing anabolic benefit and longevity risk)

nmol/L

The clinical range defines what is considered medically “normal” — broad enough to cover 95% of the population. The performance range reflects where research and clinical experience suggest most people feel and function at their best.


Why It Matters

Why IGF-1 matters for performance

IGF-1 sits at the intersection of performance and longevity — and the optimal range is a deliberate trade-off. Higher IGF-1 (within range) supports muscle growth, recovery, bone density, and cognitive function. But persistently elevated IGF-1 above the reference range is associated with increased cancer risk in epidemiological studies, because the same growth-promoting signals that repair tissue also accelerate tumour cell proliferation. For active adults, the goal is a healthy mid-range IGF-1: high enough to support recovery and lean mass, low enough to avoid excess proliferative signalling. Low IGF-1 in younger adults often signals poor protein intake, chronic caloric restriction, liver dysfunction, or growth hormone deficiency — all of which impair recovery and accelerate sarcopenia.


Symptoms

Signs your levels may be off

Low / Deficiency

  • Reduced muscle mass and slow recovery from training
  • Increased body fat, particularly visceral
  • Poor wound healing and slow tissue repair
  • Low bone density and increased fracture risk
  • Fatigue and reduced exercise tolerance
  • Cognitive decline and poor memory
  • Thin skin and premature ageing

High / Excess

  • Acromegaly features (enlarged hands, feet, jaw — if GH-driven)
  • Joint pain and stiffness
  • Increased risk of colorectal, breast, and prostate cancer (epidemiological association)
  • Skin tags and thickened skin
  • Insulin resistance (IGF-1 and insulin share receptor cross-talk)

Dietary Sources

Foods that support IGF-1 levels

Adequate protein (1.6–2.2 g/kg/day — protein intake is the strongest dietary driver of IGF-1)Dairy (milk and whey are potent IGF-1 stimulators, independent of total protein)Zinc-rich foods (oysters, beef — zinc deficiency directly suppresses IGF-1)Adequate calories (chronic caloric restriction reliably suppresses IGF-1)Sleep (7–9 hours — GH is released primarily during deep sleep, driving next-day IGF-1)

Supplementation

Evidence-based supplementation

IGF-1 is not directly supplemented over the counter. It is modulated through lifestyle: adequate protein intake (1.6–2.2 g/kg/day), sufficient calories to avoid chronic energy deficit, quality sleep (7–9 hours — growth hormone is released primarily during slow-wave sleep), and resistance training (heavy compound movements transiently increase GH secretion). Zinc deficiency directly suppresses IGF-1 — supplement 15–30 mg/day if serum zinc is low. Vitamin D deficiency is also associated with lower IGF-1 levels. Intermittent fasting transiently suppresses IGF-1 (this is part of the proposed longevity mechanism of fasting, but may be counterproductive for muscle preservation). If IGF-1 is persistently below range despite adequate nutrition, a GP referral for GH stimulation testing is warranted — adult growth hormone deficiency is underdiagnosed and treatable. Conversely, if IGF-1 is persistently above range, investigation for acromegaly is essential. Retest at 90 days after any lifestyle change, fasted morning draw preferred.


Research

Key study

Serum insulin-like growth factor I and risk of cancer: results from the EPIC study

Rinaldi S, Cleveland R, Norat T, et al.

International Journal of Cancer (2010)

DOI: 10.1002/ijc.25007

Related Biomarkers


Related Guides


Test your IGF-1 levels

IGF-1 is included in the Helvy 50+ biomarker panel. Get your results in 5 days with a personalised protocol.

Order Your Test

This content is for educational purposes only and does not constitute medical advice. Your data suggests areas for optimisation, but any concerns should be discussed with a qualified healthcare professional. If your results flag values outside safe ranges, we recommend consulting your GP.